human
parainfluenza
virus
hpiv
distribut
worldwid
involv
mainli
pathogenesi
respiratori
tract
infect
develop
optim
three
quantit
revers
transcript
real
time
polymeras
chain
reaction
rt
real
time
qtpcr
indirect
immunofluoresc
ifa
detect
quantit
clinic
sampl
describ
effici
sensit
specif
interand
intraassay
variabl
turnaround
time
two
method
compar
assay
valid
bronchoalveolar
lavag
specimen
base
result
obtain
molecular
method
repres
valid
rapid
tool
clinic
manag
includ
diagnost
panel
aim
evalu
suspect
respiratori
tract
infect
prototyp
viru
strain
strain
strain
greer
strain
obtain
american
type
cultur
collect
atcc
manassa
va
respect
onehundr
thirtyon
bronchoalveolar
lavag
specimen
thaw
liquefi
nacetylcistein
obtain
patient
malefemal
median
age
differ
clinic
set
examin
inform
consent
obtain
patient
nearest
rel
studi
approv
ethic
committe
univers
hospit
san
giovanni
battista
turin
human
laryng
epidermoid
carcinoma
cell
african
green
monkey
kidney
epitheli
vero
cell
use
primari
viral
isol
propag
cell
line
obtain
zooprofilatt
institut
lombardi
emilia
romagna
bs
tcl
bs
cl
respect
vero
cell
maintain
c
co
supplement
mem
paa
laboratori
gmbh
pasch
austria
contain
filter
glutamin
antibiot
agent
penstrep
sigmaaldrich
saint
loui
mo
antimycot
agent
fungizon
bristolmy
squibb
sermoneta
itali
fetal
calf
serum
fc
paa
laboratori
gmbh
infect
carri
confluenc
infect
flake
falcon
becton
dickinson
milano
itali
inocul
solut
contain
l
viral
stock
ml
mem
fc
medium
infect
contain
fc
supplement
gml
trypsin
gibco
invitrogen
carlsbad
ca
flake
inocul
viru
use
control
cell
maintain
h
c
co
assist
viral
adsorpt
subsequ
inoculum
remov
mem
fc
ad
cell
monolay
observ
daili
cytopath
effect
cpe
viru
recov
cellular
media
centrifug
min
g
supernat
kept
ice
cell
monolay
scrape
thermal
treatment
perform
extract
viral
particl
cell
consist
rapid
freez
liquid
nitrogen
follow
defrost
c
three
time
recov
viral
particl
store
c
nineti
sixwel
plate
confluenc
vero
inocul
l
dilut
viru
medium
ie
neg
control
tcid
assay
plate
observ
daili
cpe
evalu
ifa
sensit
dilut
rang
tcid
l
titrat
viru
obtain
differ
variabl
day
incub
day
primari
monoclon
antibodi
dilut
mab
albumin
supplement
pb
examin
two
hundr
microlit
tcid
dilut
inocul
shell
vial
confluenc
inoculum
adsorpt
enhanc
centrifug
g
min
one
millilitr
supplement
medium
ad
shell
vial
kept
thermostat
incub
cell
fix
ml
acetonemethanol
min
subsequ
slide
incub
gener
antihpiv
mab
lot
argen
verniol
franc
c
goat
antimous
fluoresceinconjug
monoclon
antibodi
lot
argen
secondari
antibodi
c
slide
wash
read
immedi
use
fluoresc
microscop
presenc
bright
green
fluoresc
within
intact
cell
consid
posit
slide
intact
cell
consid
inadequ
examin
optim
ifa
condit
use
reproduc
within
singl
run
n
intraassay
variabl
differ
run
experi
n
interassay
variabl
use
three
dilut
dilut
sensit
level
one
tabl
nucleic
acid
extract
perform
use
nuclisen
easymag
marci
letoil
franc
viral
cdna
gener
first
incub
random
primer
ngl
dntp
mm
invitrogen
l
rna
min
c
subsequ
mix
contain
dtt
buffer
mm
trishcl
ph
mm
kcl
superscript
tm
ii
rt
ul
rnaseout
tm
ul
invitrogen
ad
total
volum
l
reaction
mixtur
incub
min
c
min
c
min
c
use
fast
thermal
cycler
appli
biosystem
monza
itali
align
virusspecif
hn
gene
base
avail
sequenc
public
databas
perform
clc
free
workbench
softwar
clc
bio
consensu
primer
probe
design
within
hn
region
use
primer
express
softwar
appli
biosystem
oligoperfect
tm
design
softwar
invitrogen
tabl
primer
probe
design
made
accord
standard
requir
prevent
primerdim
format
melt
temperatur
tm
primer
c
order
confirm
rnadna
extract
prevent
fals
neg
result
housekeep
gene
gapdh
coamplifi
use
intern
control
vic
probe
appli
biosystem
tabl
product
plasmid
standard
cdna
fragment
virusspecif
hn
sequenc
clone
ta
vector
propag
compet
escherichia
coli
cell
plasmid
creat
use
topo
ta
pcr
clone
kit
invitrogen
accord
manufactur
specif
concentr
plasmid
dna
quantifi
use
highresolut
spectrophotomet
optim
three
rt
real
time
qtpcr
two
differ
concentr
target
primer
probe
evalu
mm
mm
mm
mm
two
microlit
cdna
ad
l
reaction
mix
give
final
reaction
volum
l
uracildna
glycosylas
use
elimin
pcr
carri
contamin
previou
pcr
quint
et
al
tetzner
et
al
amplif
profil
optim
real
time
pcr
system
appli
biosystem
follow
one
cycl
decontamin
c
min
one
cycl
denatur
c
min
follow
cycl
amplif
c
c
run
standard
curv
gener
rang
serial
dilut
plasmid
standard
linear
rang
evalu
use
dilut
copiesreact
plasmid
intraand
interassay
coeffici
variabl
cv
evalu
use
differ
concentr
plasmid
standard
rang
copiesreact
within
singl
run
n
differ
run
experi
n
differ
concentr
tcid
rang
reaction
amplifi
rt
real
time
qtpcr
order
compar
sensit
specif
two
diagnost
approach
gener
antihpiv
mab
test
potenti
crossreact
unrel
virus
bacteria
influenza
viru
atcc
atcc
influenza
viru
b
atcc
adenoviru
atcc
rsv
atcc
cmv
atcc
hsv
atcc
human
rhinovirus
atcc
human
coxsackieviru
type
atcc
echoviru
type
atcc
atcc
enteroviru
type
atcc
human
coronaviru
type
atcc
atcc
streptococcu
pneumonia
atcc
legionella
pneumophila
atcc
mycoplasma
pneumonia
atcc
chlamydia
pneumonia
atcc
similarli
primer
probe
test
use
strain
human
sequenc
base
data
avail
blast
align
softwar
http
blastncbinlmnihgovblastcgi
signific
homolog
sequenc
found
viral
cpe
consist
cell
round
focal
destruct
monolay
syncyti
format
vero
cell
show
differ
suscept
hpiv
infect
tcid
ml
vero
cell
unabl
support
growth
presenc
trypsin
day
vero
respect
day
vero
respect
day
sensit
tcid
day
fig
signific
differ
observ
day
singl
posit
cell
show
granular
cytoplasm
fluoresc
seen
lower
tcid
eg
higher
tcid
eg
rare
syncyti
format
appreci
differ
mab
dilut
term
fluoresc
intens
decrement
use
dilut
evid
data
shown
day
sensit
vero
cell
tcid
tcid
respect
fig
granular
cytoplasm
fluoresc
infect
cellular
foci
spread
infect
pattern
lower
tcid
eg
observ
higher
tcid
eg
fluoresc
involv
nucleu
vero
cell
stain
intens
result
depend
mab
dilut
reduc
constantli
increas
mab
dilut
signific
differ
observ
cell
day
sensit
vero
cell
tcid
tcid
respect
fig
lower
intens
fluoresc
seen
high
mab
dilut
comparison
sinc
cell
low
sensit
day
postinfect
cell
cultur
prolong
day
howev
result
increment
sensit
widespread
homogen
cytoplasm
fluoresc
pattern
cellular
model
lower
tcid
eg
observ
higher
tcid
eg
syncyti
format
seen
interestingli
infect
pattern
noth
first
dilut
higher
sensit
threshold
spread
stain
appear
complet
neg
tabl
reproduc
sensit
ie
lowest
tcid
concentr
detect
frequenc
ifa
report
rt
real
time
qtpcr
optim
paramet
obtain
lowest
detect
limit
high
specif
result
follow
concentr
primer
mm
probe
mm
forward
primer
mm
revers
mm
probe
mm
amplif
dynam
rang
three
rt
real
time
qtpcr
assay
assess
carri
serial
dilut
plasmid
standard
copiesreact
follow
copiesreact
fig
fig
fig
sensit
rt
real
time
qtpcr
defin
lowest
concentr
target
quantifi
frequenc
found
copyreact
copiesreact
rt
real
time
qtpcr
sensit
found
tcid
reaction
data
shown
inclus
intern
control
gapdh
target
induc
loss
primari
target
sensit
amplif
data
shown
result
intraand
interassay
reproduc
summar
tabl
rt
real
time
qtpcr
quantit
follow
formula
use
lower
limit
virusspecif
dynam
rang
correct
factor
deriv
analyt
procedur
inferior
limit
geqml
bronchoalveolar
lavag
geqml
case
bronchoalveolar
lavag
specimen
posit
ifa
versu
rt
real
time
qtpcr
three
specimen
coinfect
one
two
viral
load
follow
specimen
rang
geqml
mean
median
mean
median
develop
standardis
three
inhous
rt
real
time
qtpcr
ifa
detect
clinic
sampl
describ
differ
ifa
condit
evalu
cellular
model
day
postinfect
mab
concentr
accord
featur
replic
cycl
hpiv
vainionpaa
hyypia
cytoplasm
stain
infect
cell
observ
although
becam
nuclear
infect
syncyti
infect
day
postinfect
two
cellular
model
show
differ
suscept
hpiv
infect
case
sensit
tcid
day
postinfect
use
mab
concentr
similar
obtain
other
aguilar
et
al
cell
tcid
calcul
vero
cell
attain
ineffici
growth
presenc
trypsin
necessari
attach
vero
cell
suitabl
detect
sensit
tcid
day
postinfect
use
mab
dilut
versu
found
aguilar
et
al
typic
spread
stain
reflect
infect
strategi
contigu
cell
infect
subsequ
sensit
tcid
vero
cell
day
postinfect
use
mab
dilut
versu
found
aguilar
et
al
pattern
infect
ie
noth
like
reflect
simultan
infect
nuclear
cytoplasm
structur
note
although
primari
mab
abl
recogn
simultan
without
differenti
viru
indic
manufactur
fluoresc
pattern
observ
specif
viru
thu
permit
discrimin
ifa
absenc
coinfect
also
intens
differ
relat
mab
dilut
cellular
model
employ
stain
vero
cell
mab
dilutiondepend
high
dilut
result
unfocus
blur
fluoresc
wherea
cell
show
similar
intens
reduct
dilut
consid
three
rt
real
time
qtpcr
assay
ident
thermal
profil
use
thu
permit
amplifi
target
work
session
assay
optim
identifi
improv
primerprob
concentr
order
obtain
highest
amplif
effici
evalu
dynam
rang
sensit
reproduc
viru
sensit
two
diagnost
approach
compar
term
amplif
fix
tcid
concentr
follow
rt
real
time
qtpcr
versu
ifa
sensit
data
obtain
rt
real
time
qtpcr
superior
obtain
investig
employ
multiplex
rtpcr
rt
real
time
pcr
protocol
includ
hpiv
osiowi
aguilar
et
al
templeton
et
al
hamanohasegawa
et
al
cordey
et
al
regard
multiplex
differ
could
due
decreas
sensit
attribut
simultan
amplif
differ
target
shown
evalu
clinic
specimen
sensit
rt
real
time
qtpcr
express
tcid
higher
ifa
data
shown
like
due
fact
detect
limit
ifa
higher
comparison
molecular
method
anoth
factor
consid
larg
volum
laboratori
prompt
clinic
decis
turnaround
time
studi
ifa
requir
day
result
rt
real
time
qtpcr
obtain
within
h
accord
previou
studi
kuyper
et
al
molecular
method
includ
diagnost
workup
abl
detect
wide
rang
respiratori
virus
clinic
manag
patient
suspect
airway
infect
tivjelunglindel
et
al
anoth
relev
advantag
autom
molecular
protocol
nucleic
acid
extract
quantif
fluoresc
signal
thu
limit
drawback
deriv
labour
intens
timeconsum
operatordepend
method
ifa
conclus
molecular
method
result
signific
improv
ifa
term
sensit
applic
turnaround
time
repres
valid
tool
clinic
manag
patient
suspect
respiratori
tract
infect
